Quthero is developing novel treatments for rapid, active, and scarless healing for skin wounds (surgical wounds, burns, chronic ulcers) and internal tissues. The technology enables perfect epithelial restoration, which accelerates time to wound closure, inhibits scar tissue formation, and eliminates complications and risks of impaired and improper healing (including infection, pain, amputation, immobility, reduced life expectancy, and morbidity). Quthero’s technology is validated in multiple animal wound healing models and in human skin grafts, demonstrating 60-200% faster wound healing than current standards of care.
Location: United States, Florida, Miami
Employees: 11-50
Total raised: $500K
Investors 2
| Date | Name | Website |
| - | Creative D... | creativede... |
| - | Tachyon Ve... | tachyon.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.03.2024 | - | $500K | - |
Mentions in press and media 3
| Date | Title | Description |
| 12.03.2024 | Quthero Raises $500K in Funding | Quthero, a Toronto, Canada-based biotech company providing a Q-peptide platform, raised $500K in funding. The round, which was raised in addition to a co-investment of $850K for a total round size of $1.35M, saw participation from Ontario C... |
| 12.03.2024 | Canada-based Quthero USD 500K in funding | Canada-based, a pioneering biotech company renowned for its unique Q-peptide platform technology, raised USD 500,000 in investment funding. The round took place on March 11, 2024. The Ontario Centre of Innovation’s (OCI) Life Science Innova... |
| - | Quthero | “Quthero” |